Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Allete Keeps Quarterly Dividend at $0.705 a Share, Payable Dec. 1 to Shareholders of Record on Nov. 15
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Allete Keeps Quarterly Dividend at $0.705 a Share, Payable Dec. 1 to Shareholders of Record on Nov. 15
Nov 3, 2024 11:58 AM
04:50 PM EDT, 10/25/2024 (MT Newswires) --
Price: 64.30, Change: -0.03, Percent Change: -0.05
Previous page:
EZCORP Prices $300 Million Senior Notes Offering
Next page:
Interparfums Insider Sold Shares Worth $2,934,603, According to a Recent SEC Filing
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
EZCORP Prices $300 Million Senior Notes Offering
Mar 25, 2025
04:34 AM EDT, 03/25/2025 (MT Newswires) -- EZCORP ( EZPW ) said late Monday it priced a private offering of $300 million of senior notes due 2032, with an interest rate of 7.375% per year. The offering is set to close on Friday, subject to customary conditions, the company said. The net proceeds are expected to be approximately $292.5 million....
Interparfums Insider Sold Shares Worth $2,934,603, According to a Recent SEC Filing
Mar 25, 2025
04:28 AM EDT, 03/25/2025 (MT Newswires) -- Philippe Benacin, 10% Owner, Director, President Interparfums, on March 21, 2025, sold 25,000 shares in Interparfums (IPAR) for $2,934,603. Following the Form 4 filing with the SEC, Benacin has control over a total of 6,846,064 common shares of the company, with 6,846,064 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/822663/000175392625000479/xslF345X05/primary_doc.xml ...
Alumis, Kaken Pharmaceutical Enter Collaboration, Licensing Deal for Dermatology Drug
Mar 25, 2025
04:28 AM EDT, 03/25/2025 (MT Newswires) -- Alumis ( ALMS ) and Kaken Pharmaceutical have struck a collaboration and licensing agreement to develop, manufacture and commercialize ESK-001 for dermatology indications in Japan, with an option to expand the license to include rheumatological and gastrointestinal diseases, the companies said Tuesday. Under the terms of the agreement, Alumis ( ALMS ) will...
BlackRock launches first bitcoin product in Europe
Mar 25, 2025
LONDON, March 25 (Reuters) - BlackRock ( BLK ) has launched its first bitcoin exchange-traded product in Europe, in a bid to tap growing demand for cryptocurrency exposure in new markets after attracting more than $50 billion into similar products in the United States. The world's largest asset manager has launched its 'iShares Bitcoin ETP', according to a BlackRock (...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP